Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 9/20 | 0.58 |
| ▸ | LPAR2 | Q9HBW0 | 7/20 | 0.58 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | CDC25A | P30304 | 1/20 | 0.46 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.46 |
| ▸ | AKT1 | P31749 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL177971 | 0.98 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL11497471 | 0.98 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL7864884 | 0.98 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL1261048 | 0.98 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL177765 | 0.98 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL24172978 | 0.98 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL28608718 | 0.98 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL5850373 | 0.98 | LPAR3 (0.61) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL11213473 | 0.93 | LPAR3 (0.57) | LPAR3LPAR2LPAR1CYP3A4LMNA | |
| SCHEMBL178128 | 0.92 | CYP3A4 (0.64) | LPAR3LPAR2LPAR1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114773417-B | Cordycepin phosphate and preparation method and application thereof | 郑州大学 | 2023-08-22 | — | — | CN | claimed |
| CN-114773417-A | Cordycepin phosphate and preparation method and application thereof | 郑州大学 | 2022-07-22 | — | — | CN | claimed |
| US-20030083490-A1 | Solution phase synthesis of oligonucleotides | AVECIA LIMITED | 2003-05-01 | — | — | US | claimed |
| EP-1003758-B1 | SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES | AVECIA LTD (GB) | 2003-04-09 | — | — | EP | claimed |
| JP-2001515086-A | — | — | 2001-09-18 | — | — | JP | claimed |
| EP-1003758-A2 | SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES | Avecia Limited (GB) | 2000-05-31 | — | — | EP | claimed |
| WO-1999009041-A2 | SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES | AVECIA LIMITED (GB) | 1999-02-25 | — | — | WO | claimed |
| EP-0370317-B1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED 2-CHLOROPYRIDINES | BAYER AG (DE) | 1993-06-02 | — | — | EP | claimed |
| US-5010201-A | Process for the preparation of substituted 2-chloropyridines | BAYER AKTIENGESELLSCHAFT (DE) | 1991-04-23 | — | — | US | claimed |
| EP-4730479-A2 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | Kyoto University (JP) | 2026-04-22 | — | — | EP | disclosed |
| US-20250246685-A1 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | KYOTO UNIVERSITY (JP) | 2025-07-31 | — | — | US | disclosed |
| EP-4428982-A1 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | Kyoto University (JP) | 2024-09-11 | — | — | EP | disclosed |
| WO-2024132849-A1 | PPS COMPOSITION, PROCESS FOR PREPARATION, PROCESS FOR PRODUCING AN ARTICLE, AND ARTICLE MADE OF THE COMPOSITION | DSM IP ASSETS B.V. (NL) | 2024-06-27 | — | — | WO | disclosed |
| CN-118056309-A | Flame-retardant nonaqueous electrolyte and secondary battery using same | 国立大学法人京都大学 | 2024-05-17 | — | — | CN | disclosed |
| US-5010201-A | Process for the preparation of substituted 2-chloropyridines | BAYER AKTIENGESELLSCHAFT (DE) | 1991-04-23 | — | — | US | disclosed |
| US-4851399-A | Isoquinoline derivatives and their use as anti-cancer agents | GLAXO GROUP LIMITED (GB) | 1989-07-25 | — | — | US | disclosed |
| US-4222930-A | VULCANIZABLE RUBBER, SILICEOUS FILLER | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1980-09-16 | — | — | US | disclosed |
| US-4212757-A | Peroxygen bleaching and compositions therefor | FMC CORPORATION (US) | 1980-07-15 | — | — | US | disclosed |
| US-4152347-A | REINFORCING AGENTS IN VULCANIZABLE RUBBER MIXTURES WHICH CONTAIN A SILICA FILLER | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1979-05-01 | — | — | US | disclosed |
| US-4144290-A | Production of bromoaryl chlorophosphates | BAYER AKTIENGESELLSCHAFT (DE) | 1979-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030083490-A1 | Solution phase synthesis of oligonucleotides | NUDT1, POLR2E, POLRMT | LPAR3 1903/4885LPAR2 2360/4885LPAR1 2362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.